Regulation of tolerogenic features on dexamethasone-modulated MPLA-activated dendritic cells by Myc

Paulina A. García-González, Jaxaira Maggi, Katina Schinnerling, Alejandro Sepúlveda-Gutiérrez, Lilian Soto, Oscar Neira, Ahmed M. Mehdi, Hendrik J. Nel, Bárbara Pesce, Octavio Aravena, María Carmen Molina, Diego Catalán, Ranjeny Thomas, Ricardo A. Verdugo, Juan Carlos Aguillón

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)


The potential of tolerogenic dendritic cells (tolDCs) to shape immune responses and restore tolerance has turn them into a promising therapeutic tool for cellular therapies directed toward immune regulation in autoimmunity. Although the cellular mechanisms by which these cells can exert their regulatory function are well-known, the mechanisms driving their differentiation and function are still poorly known, and the variety of stimuli and protocols applied to differentiate DCs toward a tolerogenic phenotype makes it even more complex to underpin the molecular features involved in their function. Through transcriptional profiling analysis of monocyte-derived tolDCs modulated with dexamethasone (Dex) and activated with monophosphoryl lipid A (MPLA), known as DM-DCs, we were able to identify MYC as one of the transcriptional regulators of several genes differentially expressed on DM-DCs compared to MPLA-matured DCs (M-DCs) and untreated/immature DCs (DCs) as revealed by Ingenuity Pathway Analysis (IPA) upstream regulators evaluation. Additionally, MYC was also amidst the most upregulated genes in DM-DCs, finding that was confirmed at a transcriptional as well as at a protein level. Blockade of transactivation of MYC target genes led to the downregulation of tolerance-related markers IDO1 and JAG1. MYC blockade also led to downregulation of PLZF and STAT3, transcription factors associated with immune regulation and inhibition of DC maturation, further supporting a role of MYC as an upstream regulator contributing to the regulatory phenotype of DM-DCs. On the other hand, we had previously shown that fatty acid oxidation, oxidative metabolism and zinc homeostasis are amongst the main biological functions represented in DM-DCs, and here we show that DM-DCs exhibit higher intracellular expression of ROS and Zinc compared to mature M-DCs and DCs. Taken together, these findings suggest that the regulatory profile of DM-DCs is partly shaped by the effect of the transcriptional regulation of tolerance-inducing genes by MYC and the modulation of oxidative metabolic processes and signaling mediators such as Zinc and ROS.

Original languageEnglish
Article number1171
JournalFrontiers in Immunology
Issue numberMAY
Publication statusPublished - 2019
Externally publishedYes


  • DC transcription factors
  • Dexamethasone-modulated and MPLA-activated DC
  • ROS metabollism in DC
  • Tolerance mechanism
  • Tolerogenic dendritic cells (tDC)
  • Zinc metabollism in DC

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'Regulation of tolerogenic features on dexamethasone-modulated MPLA-activated dendritic cells by Myc'. Together they form a unique fingerprint.

Cite this